Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second…
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc….
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks…
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial…
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection…
Finance
Biotech Stocks Take Centerstage as Markets Turn Red (COEP,AMLX, BMRN, EXEL,…
S&P 500 could move higher as per technical analysis (ARM, S&P)
Health Department Urges DEA to Reevaluate Marijuana Restrictions (TLRY,ACB,CURLF,CGC)
Stocks in Focus as markets take a break from rallying (QQQ,NVO,ANET)
BYND Cannasoft (BCAN): A Small-Cap Enterprise with Exceptional Growth Prospects in…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
Sorrento Therapeutics Inc
Tag: Sorrento Therapeutics Inc
Sorrento Therapeutics Inc (NASDAQ:SRNE) Reports Positive Results From Phase 1b Clinical...
Kate Hudson
-
April 21, 2021
0
Sorrento Therapeutics Inc (NASDAQ:SRNE) Signs A Deal To Acquire Exclusive Rights...
Gavins Felicity
-
May 26, 2020
0
Recent Post
Bio-Path Holdings (NASDAQ: BPTH) announces the successful completion of the second...
Gavins Felicity
-
April 18, 2024
0
Bio-Path Holdings, Inc. (NASDAQ: BPTH), a pioneer in biotechnology, has recently achieved a critical milestone in its fight against acute myeloid leukemia...
Wall Street Bulls Eye a 290% Upside on Actinium Pharmaceuticals, Inc....
April 1, 2024
Mesoblast’s (NASDAQ: MESO) Breakthrough: A New Horizon in Pediatric Treatment Sparks...
March 29, 2024
Merck Secures FDA Approval for Winrevair, Revolutionizing Treatment for Pulmonary Arterial...
March 26, 2024
Indaptus Therapeutics (NASDAQ:INDP): Pioneering the Future of Cancer and Viral Infection...
March 25, 2024